| Dr Ronald O Rigor, MD, | |
|
675 S Arroyo Pkwy, 100, Pasadena, CA 91105-3263 | |
| (626) 844-3884 | |
| (626) 844-3886 |
| Full Name | Dr Ronald O Rigor |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 30 Years |
| Location | 675 S Arroyo Pkwy, Pasadena, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700835675 | NPI | - | NPPES |
| BT689A | Other | CA | MEDICARE GROUP PTAN |
| 0268292 | Medicaid | IA | |
| BT687Z | Other | CA | MEDICARE PTAN |
| 036101791 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 36475 (Iowa) | Secondary |
| 207N00000X | Dermatology | A92405 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ronald Rigor Md Inc | 4789734989 | 2 |
News Archive
...according to an analysis of previously published research in the April 9 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Some physicians do not tell patients about treatments - such as contraception, abortion or sedation for dying patients - that they are morally opposed to, according to a study published in the Feb. 8 edition of the New England Journal of Medicine, the Washington Post reports.
Despite innovative cancer research being presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, as well as numerous other conferences organized by the American Association for Cancer Research each year, the pace of scientific discovery in cancer research will slow if Congress does not pass the pending appropriations bill for fiscal year 2011.
Imaxio, a biopharmaceutical company specialized in vaccines, together with its partners from the Jenner Institute at Oxford University, the European Vaccine Initiative and Preclin Biosystems, is pleased to announce today a European Union award of EUR 5.5 million to support the ‘Bellerophon Project' consortium to develop a vaccine against Staphylococcus aureus (S. aureus).
› Verified 2 days ago
| Entity Name | Ronald Rigor Md Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346488962 PECOS PAC ID: 4789734989 Enrollment ID: O20090707000131 |
News Archive
...according to an analysis of previously published research in the April 9 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Some physicians do not tell patients about treatments - such as contraception, abortion or sedation for dying patients - that they are morally opposed to, according to a study published in the Feb. 8 edition of the New England Journal of Medicine, the Washington Post reports.
Despite innovative cancer research being presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, as well as numerous other conferences organized by the American Association for Cancer Research each year, the pace of scientific discovery in cancer research will slow if Congress does not pass the pending appropriations bill for fiscal year 2011.
Imaxio, a biopharmaceutical company specialized in vaccines, together with its partners from the Jenner Institute at Oxford University, the European Vaccine Initiative and Preclin Biosystems, is pleased to announce today a European Union award of EUR 5.5 million to support the ‘Bellerophon Project' consortium to develop a vaccine against Staphylococcus aureus (S. aureus).
› Verified 2 days ago
| Entity Name | Diamond Bar Dermatology And Laser Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598136384 PECOS PAC ID: 9234431693 Enrollment ID: O20151231001770 |
News Archive
...according to an analysis of previously published research in the April 9 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Some physicians do not tell patients about treatments - such as contraception, abortion or sedation for dying patients - that they are morally opposed to, according to a study published in the Feb. 8 edition of the New England Journal of Medicine, the Washington Post reports.
Despite innovative cancer research being presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, as well as numerous other conferences organized by the American Association for Cancer Research each year, the pace of scientific discovery in cancer research will slow if Congress does not pass the pending appropriations bill for fiscal year 2011.
Imaxio, a biopharmaceutical company specialized in vaccines, together with its partners from the Jenner Institute at Oxford University, the European Vaccine Initiative and Preclin Biosystems, is pleased to announce today a European Union award of EUR 5.5 million to support the ‘Bellerophon Project' consortium to develop a vaccine against Staphylococcus aureus (S. aureus).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ronald O Rigor, MD, 675 S Arroyo Pkwy, 100, Pasadena, CA 91105-3263 Ph: (626) 844-3884 | Dr Ronald O Rigor, MD, 675 S Arroyo Pkwy, 100, Pasadena, CA 91105-3263 Ph: (626) 844-3884 |
News Archive
...according to an analysis of previously published research in the April 9 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Some physicians do not tell patients about treatments - such as contraception, abortion or sedation for dying patients - that they are morally opposed to, according to a study published in the Feb. 8 edition of the New England Journal of Medicine, the Washington Post reports.
Despite innovative cancer research being presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, as well as numerous other conferences organized by the American Association for Cancer Research each year, the pace of scientific discovery in cancer research will slow if Congress does not pass the pending appropriations bill for fiscal year 2011.
Imaxio, a biopharmaceutical company specialized in vaccines, together with its partners from the Jenner Institute at Oxford University, the European Vaccine Initiative and Preclin Biosystems, is pleased to announce today a European Union award of EUR 5.5 million to support the ‘Bellerophon Project' consortium to develop a vaccine against Staphylococcus aureus (S. aureus).
› Verified 2 days ago
Narineh Zohrabian, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 536 S Fair Oaks Ave, Pasadena, CA 91105 Phone: 626-817-9944 Fax: 626-817-9945 | |
Sara Y Gaspard, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 625 S Fair Oaks Ave, #200, Pasadena, CA 91105 Phone: 626-793-7790 Fax: 626-793-9018 | |
Elizabeth Nimni, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 50 Bellefontaine St Ste 104, Pasadena, CA 91105 Phone: 626-304-6300 | |
Razieh Soltani Arabshahi, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 960 E Green St, Ste 330, Pasadena, CA 91106 Phone: 626-449-4207 Fax: 626-449-0925 | |
Yuchi C Chang, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 401 S. Fair Oaks Ave, Pasadena, CA 91108 Phone: 626-405-7221 | |
Christiaan P Hallman, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 800 Fairmount Ave, Suite 310, Pasadena, CA 91105 Phone: 626-795-2007 Fax: 626-795-2012 | |
Dr. Lenore Setsuko Kakita, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 225 S Euclid Ave, Pasadena, CA 91101 Phone: 626-584-9933 Fax: 626-584-9333 |